ScholarIQanswers from OpenAlex

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice

PaperCitations, authors & open-access status

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice is a paper indexed in ScholarIQ from OpenAlex.

How many citations does CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice have?

ScholarIQcitation count

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice has 89 citations in the OpenAlex counts ScholarIQ stores.

When was CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice published?

ScholarIQyear

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice has 2013 year in the ScholarIQ index.

What is the open-access status of CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice?

ScholarIQoa status

CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice has green oa status in the ScholarIQ index.

What is the DOI of CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice?

ScholarIQdoi

The DOI for CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice is on the source record.

What is the PMID of CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice?

ScholarIQpmid

The PMID for CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice is on the source record.

What is the OpenAlex record for CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice?

ScholarIQopenalex

The OpenAlex for CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial